Background The burden of cardiovascular events in Africa is projected to rise significantly in the coming decade, placing ...

For younger acute myocardial infarction (AMI) survivors, living in marginalized neighborhoods is associated with adverse ...

There is increased risk for incident myocardial infarction among adults aged 18 to 64 years with joint exposure to ozone and increased ambient temperature.

For younger acute myocardial infarction (AMI) survivors, living in marginalized neighborhoods is associated with adverse ...

Secondary analysis findings from the EMPACT-MI trial highlight empagliflozin's significant cardiovascular and kidney benefits when initiated soon after an acute myocardial infarction.

The findings from a contemporary US cohort point to the need for better ways to identify and treat those who are at risk.

BACKGROUND: Direct reprogramming of fibroblasts to cardiomyocytes is a potentially curative strategy for ischemic heart ...

For patients with acute MI at increased risk for HF, empagliflozin showed cardiorenal benefits and was safe to initiate early ...

New 10-year data from the DANAMI-3-PRIMULTI trial show long-term benefits of complete revascularization for patients with ...

Myocardial infarction, commonly known as a heart attack, is one of the most serious heart problems people can face. It ...

When discussing heart health, the words 'myocardial infarction' and 'heart attack' are used interchangeably as if they are ...

Flinders Health and Medical Research Institute researchers, along with colleagues in the UK and U.S., have linked brighter ...